Advancing new drug therapies for unmet medical needs

Advancing new drug therapies for unmet medical needs 2017-11-01T12:17:43+00:00

Dimerix Limited is a clinical stage biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB)

Our vision is to positively improve human health by creating safe and effective new treatments for patients with unmet medical needs

Recent news and media

NDF Research DXB Nov 17 Update Report

The ASX release is available here. The NDF Research update report is available here.  

Corporate Presentation BioEurope

View this presentation here. 

Baker Young DXB Flash Note November 2017

Read this here. 

Click here to view analyst coverage
Click here to view our corporate fact sheet